331 related articles for article (PubMed ID: 9820038)
1. [The use of Maxaquin (lomefloxacin hydrochloride) in the treatment of nonspecific inflammatory diseases and in the prevention of surgical interventions in urology].
Derevianko II; Lopatkin NA; Khodyreva LA; Kondrat'eva EM
Urol Nefrol (Mosk); 1998; (5):14-8. PubMed ID: 9820038
[No Abstract] [Full Text] [Related]
2. [Efficacy of lomefloxacin in treatment of nonspecific inflammatory diseases and in prophylaxis of postoperative complications in urology].
Derevianko II; Khodyreva LA; Avdoshin VL; Andriukhin MI; Gabliia MIu
Antibiot Khimioter; 1998; 43(10):36-41. PubMed ID: 9825109
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of lomefloxacin, a new difluorinated quinolone, against urinary bacterial isolates: comparison with enoxacin and ofloxacin.
Azadian BS; Talboys CA; Roberts AP
J Chemother; 1989 Jul; 1(4 Suppl):176-7. PubMed ID: 16312357
[No Abstract] [Full Text] [Related]
4. Therapeutic effect of the quinolone prodrug prulifloxacin against experimental urinary tract infections in mice.
Tomii Y; Ozaki M; Matsuda M; Honmura T; Nishimura I; Yamaguchi R; Adachi T; Okawa Y; Nishino T
Arzneimittelforschung; 1996 Dec; 46(12):1169-73. PubMed ID: 9006794
[TBL] [Abstract][Full Text] [Related]
5. Two new fluoroquinolones.
Med Lett Drugs Ther; 1992 Jun; 34(872):58-60. PubMed ID: 1317502
[No Abstract] [Full Text] [Related]
6. [Maxaquin and ciprofloxacin in the treatment of complicated and recurrent urinary infections in adults].
Savitskaia KI; Trapeznikova MF; Nekhorosheva AG; Solodilova OE; Nasonov VN; Dutov VV; Kalinin VN; Shanina AG; Rusanova EV
Klin Med (Mosk); 1994; 72(2):38-42. PubMed ID: 8015241
[TBL] [Abstract][Full Text] [Related]
7. Criteria for use of ofloxacin and lomefloxacin in adult inpatients and outpatients.
Spivey IM
Clin Pharm; 1993 Jun; 12(6):452-8. PubMed ID: 8403817
[No Abstract] [Full Text] [Related]
8. [Lemofloxacin: antimicrobial ability and clinico-pharmacokinetic basis for use in urogenital infections].
Iakovlev SV
Urologiia; 2002; (1):11-4. PubMed ID: 11877963
[TBL] [Abstract][Full Text] [Related]
9. Quinolones for short-term treatment of uncomplicated urinary tract infection.
Kadiri S; Ajayi SO; Toki RA
East Afr Med J; 1999 Oct; 76(10):587-9. PubMed ID: 10734512
[TBL] [Abstract][Full Text] [Related]
10. In vitro sensitivities of urinary tract pathogens to lomefloxacin and five other antimicrobial agents.
Peddie BA
N Z Med J; 1989 Jun; 102(869):298. PubMed ID: 2733911
[No Abstract] [Full Text] [Related]
11. Therapeutic efficacy of ofloxacin, ciprofloxacin and NY-198 in experimentally infected normal and alloxan-induced diabetic mice.
Obana Y; Nishino T
Drugs Exp Clin Res; 1988; 14(5):327-31. PubMed ID: 3219995
[TBL] [Abstract][Full Text] [Related]
12. [Urinary tract infections: risk factors and therapeutic trends].
Margariti PA; Astorri AL; Mastromarino C
Recenti Prog Med; 1997 Feb; 88(2):65-8. PubMed ID: 9148368
[TBL] [Abstract][Full Text] [Related]
13. [Pharma-clinics. The drug of the month. Levofloxacin (Tavanic)].
Scheen AJ
Rev Med Liege; 2000 Nov; 55(11):1015-7. PubMed ID: 11195704
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of lomefloxacin and ofloxacin in complex therapy of infections in patients with burns].
Krutikov MG; Alekseev AA; Bobrovnikov AE; Grishina IA; Elagina LV; Izotova GN; Iakovlev VP
Antibiot Khimioter; 1998; 43(10):27-31. PubMed ID: 9825107
[TBL] [Abstract][Full Text] [Related]
15. [A broad-spectrum antimicrobial preparation--lomefloxacin (Maxaquin): the results of 10 years of its use in the clinics of Russia].
Padeĭskaia EN
Antibiot Khimioter; 2000; 45(1):39-44. PubMed ID: 10690427
[No Abstract] [Full Text] [Related]
16. A controlled trial of levofloxacin and lomefloxacin in the treatment of complicated urinary tract infection.
Klimberg IW; Cox CE; Fowler CL; King W; Kim SS; Callery-D'Amico S
Urology; 1998 Apr; 51(4):610-5. PubMed ID: 9586615
[TBL] [Abstract][Full Text] [Related]
17. [A clinical study of lomefloxacin on the patients with urinary tract infections--focused on lomefloxacin-induced photosensitivity reaction].
Tozawa K; Washida H; Honma H; Kang K; Yamada Y
Hinyokika Kiyo; 1993 Sep; 39(9):801-5. PubMed ID: 8213373
[TBL] [Abstract][Full Text] [Related]
18. [New fluoroquinolones in urology].
Derevianko II; Hefedova LA
Urologiia; 2004; (4):27-32. PubMed ID: 15457949
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of prulifloxacin against Escherichia coli isolated from urinary tract infections and the biological cost of prulifloxacin resistance.
Gualco L; Schito AM; Schito GC; Marchese A
Int J Antimicrob Agents; 2007 Jun; 29(6):679-87. PubMed ID: 17363225
[TBL] [Abstract][Full Text] [Related]
20. In vitro evaluation of lomefloxacin (NY-198 or SC-47111), a new difluoro-quinolone.
Jones RN
J Chemother; 1989 Jul; 1(4 Suppl):165-7. PubMed ID: 16312353
[No Abstract] [Full Text] [Related]
[Next] [New Search]
